Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Easy Upgrade

Nov 1, 2015/Column

This strategy is a definite plus.

Busting Payment Myths, Part 8: Wherefore the Payment Cut?

Jan 29, 2021/Perspective

PTs are facing Medicare payment cuts. But what does that really mean?

General Self-Efficacy Scale (GSE)

Aug 4, 2021/Test & Measure

This summary reviews a questionnaire to measure self-efficacy and contains information on use of it to screen patients or clients in a general clinical setting and reviews the use of this questionnaire with adolescents and adults in a general clinical setting without regard to a specific diagnosis or

Virtual NEXT Provides APTA Members More Than 20 Programming Hours for $20

May 13, 2020/News

Virtual NEXT provides APTA members more than 20 programming hours for $20.

APTA Recognized as HHS National Youth Sports Strategy Champion

May 19, 2023/News

The association joins national and local organizations as an advocate for youth access to sports, regardless of ability.

Variation in Rehabilitation After Hip Fracture and the Effect on Hospital Readmissions: PTJ Author Interview With Amit Kumar

May 23, 2023/Podcast

A discussion on the importance of increased rehabilitation after hip fracture.

Valsalva Test

Jun 17, 2014/Test & Measure

Aids in the clinical diagnosis of problems or injury in the nerves of the cervical spine.

Orlando, The City I Call Home

Apr 23, 2018/Perspective

Join us in Orlando, Florida, for NEXT.

From Near Death To Walking Steady: A COVID-19 Survivor's Journey

Jul 16, 2020/Podcast

Brian de Castro didn't fit the profile of someone likely to find himself in a life-and-death battle with COVID-19. His entire family got the virus and recovered quickly, but the 39-year-old who was in good health, is required two weeks on a ventilator. Physical therapy was key to his recovery.

Study: Even Small Amounts of PA Can Reduce CVD Risk Among the Elderly

Dec 4, 2017/Review

This study is notable because of its focus on participants 65 and older, and its 18-year median follow-up duration.